Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Clinical trial NCT07093476 · RECRUITING
Trial details
- NCT number
- NCT07093476
- Sponsor
- Celltrion
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2026-12-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.